IRLAB Therapeutics AB (publ) (IRLAB-A) — Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

IRLAB Therapeutics AB (publ) (IRLAB-A) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of Skr5.26 Million represents 1% of operating cash flow (Skr5.26 Million). Read IRLAB-A current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

Skr5.26 Million

SEK

Operating Cash Flow

Skr5.26 Million

SEK

Capital Expenditures

Skr0.00

SEK

IRLAB Therapeutics AB (publ) Free Cash Flow Generation Index (2021–2021)

Historical FCF Generation Index trend for IRLAB Therapeutics AB (publ) across 1 annual periods. Explore IRLAB Therapeutics AB (publ) capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for IRLAB Therapeutics AB (publ) (2021–2021)

Year-by-year Free Cash Flow Generation Index for IRLAB Therapeutics AB (publ). For the full company profile including market capitalisation, see IRLAB Therapeutics AB (publ) (IRLAB-A) market capitalisation.

Year	FCG Index	Free Cash Flow (SEK)	Operating CF	Capital Expenditures	YoY Change
2021	0.99x	Skr127.93 Million	Skr128.64 Million	Skr708.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).